The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil

Anaesthesia

Volumn 56, Issue 5, 2001, Pages 408-413

  Peden, C J ^a   Cloote, A H ^b   Stratford, N ^c   Prys Roberts, C ^d  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Anaesthetics, intravenous: propofol; Premedication: dexmedetomidine; Receptor: alpha 2

Indexed keywords

ALFENTANIL; DEXMEDETOMIDINE; PROPOFOL;

ADULT; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INFUSION; GENERAL ANESTHESIA; HEMODYNAMIC PARAMETERS; HUMAN; MOTOR ACTIVITY; PHASE 2 CLINICAL TRIAL; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL; SEDATION; SINUS ARREST; VERTIGO;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ADULT; ALFENTANIL; ANALYSIS OF VARIANCE; ANESTHETICS, INTRAVENOUS; BRADYCARDIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EPINEPHRINE; HUMANS; HYPNOTICS AND SEDATIVES; NOREPINEPHRINE; PREANESTHETIC MEDICATION; PROPOFOL; RADIOIMMUNOASSAY;

EID: 0035010717     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2001.01553.x     Document Type: Article

References (26)

1. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991; 74: 581-605.
2. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999; 54: 146-65.
3. 2-adrenoceptor agonists and anaesthesia. In: Prys-Roberts C, Brown BR Jr, eds. International Practice of Anaesthesia. Oxford: Butterworth-Heinemann, 1996, 1/19/1-15.
4. 2-adrenergic receptor. Anesthesiology 1988; 69: 818-23.
5. 2-adrenoceptors. Anesthesiology 1989; 71: 75-9.
6. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. Journal of Pharmacology and Applied Therapeutics 1984; 230: 232-6.
7. 2-adrenoceptors in the human central nervous system. Neuroscience 1994; 59: 589-98.
8. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesthesia and Analgesia 1992; 75: 940-6.
9. Scheinin H, Jaakola M-L, Sjovall S, et al. Intramuscular dexmedetomidine as premedication for general anesthesia. Anesthesiology 1993; 78: 1065-75.
10. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54: 1136-42.
11. Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. British Journal of Anaesthesia 1999; 83: 372-80.
12. Fragen RJ, Fitzgerald PC. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults aged 55-70 years. Journal of Clinical Anesthesia 1999; 11: 466-70.
13. Goldstein DS, Feuerstein G, Izzo JL, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of NE and E in man. Life Science 1981; 28: 467-75.
14. Plummer GF. An improved method for the determination of propofol (IC135,868) in blood. Journal of Chromatography 1987; 421: 171-6.
15. Michiels M, Hendriks R, Heykants J. Radioimmunoassay of the new opiate analgesics alfentantil and sufentanil. Pharmacokinetic profile in man. Journal of Pharmacy and Pharmacology 1984; 35: 86-93.
16. Vuorilehto L, Salonen JS, Anttila M. Picogram level determination of medetomidine in dog serum by capillary gas chromatography with negative ion chemical ionization mass spectrometry. Journal of Chromatography 1989; 497: 282-7.
17. Forrest F, Tooley M, Saunders P, Prys-Roberts C. Propofol infusion and the suppression of consciousness: the EEG and dose requirements. British Journal of Anaesthesia 1994; 72: 35-41.
18. Richards MJ, Skues MA, Jarvis AP, Prys-Roberts C. Total IV anaesthesia with propofol and alfentanil: dose requirements for propofol and the effect of premedication with clonidine. British Journal of Anaesthesia 1990; 65: 157-63.
19. Aanta R, Jaakola M-L, Kallio A, Kanto J Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology 1997; 86: 1055-60.
20. Buhrer M, Mappes A, Lauber R, Stanski DR, Maitre PO. Dexmedetomidine decreases thiopental dose requirement and alters distribution pharmacokinetics. Anesthesiology 1994; 80: 1216-27.
21. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II Hemodynamic changes. Anesthesiology 1992; 77: 1134-42.
22. Taittonen MT, Kirvela OA, Aantaa R, Kanto JH. Effect of clonidine and dexmedetomidine premedication on perioperative oxygen consumption and haemodynamic state. British Journal of Anaesthesia 1997; 78: 400-6.
23. 2-adrenoceptor antagonist atipamezole. Anesthesiology 1998; 89: 574-84.
24. Talke P, Li J, Jam U, et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology 1995; 82: 620-35.
25. Thornton C, Lucas MA, Newton DEF, Dore CJ, Jones RM. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 2: Auditory and somatosensory evoked responses. British Journal of Anaesthesia 1999; 83: 381-6.
26. Talke P. Receptor-specific reversible sedation: beginning of a new era of anesthesia? Anesthesiology 1998; 89: 560-1.